Table 1 Sample and study design characteristics of selected records
Study | Article/ poster | Study design | Sample description | Disease status | WPAI version |
|---|---|---|---|---|---|
Cohen 2014 [30] | Article | Cross-sectional | 220 patients with IBD (95 with UC) enrolled in a patient registry in the US in 2008–2009 | Mixed (75% remission, 25% active) | WPAI:GH |
Gibson 2014 [31] | Article | Cross-sectional | 175 outpatients with UC attending specialist consultations in Australia in 2011 | Mixed (54% remission, 46% active [17% mild, 30% moderate/severe]) | WPAI:UC |
Mandel 2014 [32] | Article | Cross-sectional | 443 patients with IBD (183 with UC) at specialized IBD centers in Hungary | Mixed (75% remission, 25% active) | WPAI:UC |
Meijs 2014 [33] | Article | Cross-sectional | 58 inpatients with UC that were hospitalized in the Netherlands in 2008–2011 | Remission (50% medication, 50% post-surgical) | WPAI:UC |
Travis 2017 [29] | Article | Open-label non-comparative interventional | 463 patients with UC from 92 study sites in Europe, Asia, and North America in 2012-2015 | All active at study baseline (moderate/severe) | WPAI:GH |
Vaizey 2014 [34] | Article | Cross-sectional | 173 outpatients with UC visiting a gastroenterologist in the UK in 2011–2012 | Mixed (58% remission, 42% active [18% mild, 24% moderate/severe]) | WPAI:UC |
van Assche 2016 [35] | Article | Cross-sectional | 253 patients with UC recruited at investigative sites from 11 European countries | Mixed (20% remission, 80% active) | WPAI:UC |
Yarlas 2015a [36] | Article | Open-label non-comparative interventional | 309 patients with UC recruited at investigative sites from the US in 2007–2009 | All active at acute phase baseline, all in remission at maintenance phase baseline | WPAI:UC |
Jackson 2016 [38] | Poster | Cross-sectional | 81 patients with IBD (31 with UC) attending a tertiary clinic in Australia in 2015 | Mixed (NOS) | WPAI:GH |
Katz Avitan 2016 [39] | Poster | Cross-sectional | 405 patients with IBD (150 with UC) attending a tertiary hospital in Israel 2015 | Mixed (67% remission, 33% active) | WPAI:UC |
Willshire 2014 [40] | Poster | Open-label non-comparative interventional | 717 patients with UC recruited at investigative sites globally | All active at acute phase baseline, all in remission at maintenance phase baseline | WPAI:UC |
Yarlas 2014 [41] | Poster | Open-label non-comparative interventional | 717 patients with UC recruited at investigative sites globally | All active at acute phase baseline, all in remission at maintenance phase baseline | WPAI:UC |
Yarlas 2015b [37] | Poster | Open-label non-comparative interventional | 717 patients with UC recruited at investigative sites globally | All active at acute phase baseline, all in remission at maintenance phase baseline | WPAI:UC |